The authors report the case of a 44-year-old man with a long history of chronic enduring
schizophrenia who experienced dramatic weight loss after commencing treatment with …

Objective Clozapine is the first choice in drug-resistant schizophrenia but also causes
important weight changes. This might discourage clinicians who are concerned about the …

Background: Obesity is a major complication of antipsychotic drugs. This study evaluated the
effect of long-term exercise on drug-induced obesity in schizophrenic patients. Methods …

Introduction Clozapine, while effective in treatment refractory schizophrenia, is associated
with significant weight gain, heart disease and increased risk of type 2 diabetes mellitus …

This paper attempts to highlight the changes associated with antipsychotic use in drug-naive
first episode schizophrenia on metabolic and anthropometric variables. It is a randomized …

Background People with serious mental illness have a three-fold increased mortality from
natural causes (1). They are also less likely to have their physical illness diagnosed and …

INTRODUCTION: Antipsychotic medication and lifestyle factors are implicated in the high
rates of obesity and metabolic syndrome in schizophrenia. While the two Consensus …

The present study is an exploratory analysis of the “Metformin for Weight Loss and Metabolic
Control in Overweight Patients with Schizophrenia and Schizoaffective Disorder”(METS) …

The National Institute of Mental Health convened a meeting in October 2005 to review the
literature on obesity, nutrition, and physical activity among those with mental disorders. The …